Human medicines European public assessment report (EPAR): Bonviva, ibandronic acid, Osteoporosis, Postmenopausal, Date of authorisation: 23/02/2004, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Breast Neoplasms;Triple Negative Breast Neoplasms, Date of authorisation: 22/11/2021, Revision: 3, Status: Authorised
EMA business hours over Assumption Day, 15 August
EMA's response to the COVID-19 pandemic: Putting people's health first
Release notes - production release version 1.6.30 July 2023 - Veterinary Medicinal Products Regulation: Union Product Database
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Psoriasis, Date of authorisation: 17/09/2018, Revision: 10, Status: Authorised
Non-Clinical and New Approach Methodologies European Specialised Expert Community
Mandate, objective and rules of procedure for the Non-Clinical and New Approach Methodologies European Specialised Expert Community
Revocation of authorisation for sickle cell disease medicine Adakveo